Y, Z., H, L., F, W., M, L., N, W., S, Z., . . . Z, G. (2026). Targeting mitochondrial TRIP13-AIF interaction suppresses myeloid leukemia progression and overcomes drug resistance. Oncogene. https://doi.org/10.1038/s41388-026-03852-3
Chicago Style (17th ed.) CitationY, Zhu, et al. "Targeting Mitochondrial TRIP13-AIF Interaction Suppresses Myeloid Leukemia Progression and Overcomes Drug Resistance." Oncogene 2026. https://doi.org/10.1038/s41388-026-03852-3.
MLA (9th ed.) CitationY, Zhu, et al. "Targeting Mitochondrial TRIP13-AIF Interaction Suppresses Myeloid Leukemia Progression and Overcomes Drug Resistance." Oncogene, 2026, https://doi.org/10.1038/s41388-026-03852-3.
Warning: These citations may not always be 100% accurate.